Vir Biotechnology Inc. (VIR)
10.57
0.35 (3.37%)
At close: Jan 15, 2025, 12:38 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -2.19 | 6.51 | 10.29 | -10.68 | -7.75 | -11.72 | -19.45 |
| PS Ratio | 15.66 | 2.12 | 5.00 | 47.45 | 1.90K | 1.57K | 9.12K |
| PB Ratio | 0.85 | 1.62 | 3.80 | 4.45 | 3.19 | -7.58 | -19.72 |
| P/FCF Ratio | -1.69 | 2.10 | -78.35 | -16.16 | -9.77 | -13.28 | -19.66 |
| P/OCF Ratio | -1.73 | 2.02 | -114.28 | -16.71 | -10.45 | -14.44 | -20.47 |
| OCF/S Ratio | -9.04 | 1.05 | -0.04 | -2.84 | -182.32 | -108.41 | -445.51 |
| Debt / Equity Ratio | 0.08 | 0.06 | 0.09 | 0.09 | 0.00 | -0.06 | n/a |
| Quick Ratio | 9.05 | 4.93 | 4.55 | 7.80 | 6.81 | 2.95 | 15.46 |
| Current Ratio | 9.05 | 4.93 | 4.58 | 7.80 | 6.81 | 2.95 | 15.46 |
| Asset Turnover | 0.04 | 0.56 | 0.56 | 0.07 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | n/a | 4.55 | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.39 | 0.25 | 0.37 | -0.42 | -0.41 | 0.65 | 1.01 |
| Return on Assets (ROA) | -0.32 | 0.18 | 0.27 | -0.33 | -0.34 | -0.6 | -0.28 |
| Return on Capital (ROIC) | -0.39 | 0.36 | 0.17 | -0.36 | -0.39 | -0.78 | -0.34 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 96.79% | 90.74% | 93.94% | -348.48% | -20.78K% | -11.45K% | -41.85K% |
| Net Profit Margin | -713.69% | 32.64% | 48.62% | -444.14% | -24.57K% | -13.35K% | -46.88K% |
| Pretax Profit Margin | -728.93% | 47.72% | 50.58% | -444.06% | -24.55K% | -13.41K% | -54.21K% |
| Operating Profit Margin | -794.04% | 52.71% | 25.47% | -441.64% | -25.03K% | -13.67K% | -54.70K% |
| FCF Margin | -928.71% | 100.93% | -6.38% | -293.69% | -19.49K% | -11.78K% | -46.39K% |
| EBITDA Margin | -771.47% | 52.71% | 38.71% | -430.96% | -24.40K% | -13.36K% | -54.41K% |